These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 11334326)

  • 1. Interaction between cyclosporine and acenocoumarol in a patient with nephrotic syndrome.
    Borrás-Blasco J; Enriquez R; Navarro-Ruiz A; Martinez-Ramirez M; Cabezuelo JB; Gonzalez-Delgado M
    Clin Nephrol; 2001 Apr; 55(4):338-40. PubMed ID: 11334326
    [No Abstract]   [Full Text] [Related]  

  • 2. Acenocoumarol and 6-mercaptopurine: an important drug interaction.
    Fernández MA; Regadera A; Aznar J
    Haematologica; 1999 Jul; 84(7):664-5. PubMed ID: 10406922
    [No Abstract]   [Full Text] [Related]  

  • 3. [Plausible pharmacologic interaction between fosinopril and acenocoumarol].
    de Tomás ME; Sáez L; Beltrán S; Gato A
    Med Clin (Barc); 1997 May; 108(19):757. PubMed ID: 9324602
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction of OTC drug noscapine and acenocoumarol and phenprocoumon.
    Lokhorst B; Rolfes L; Jessurun NT
    Br J Clin Pharmacol; 2019 May; 85(5):1041-1043. PubMed ID: 30809820
    [No Abstract]   [Full Text] [Related]  

  • 5. How should microemulsified Cyclosporine A (Neoral) therapy in patients with nephrotic syndrome be monitored?
    Filler G
    Nephrol Dial Transplant; 2005 Jun; 20(6):1032-4. PubMed ID: 15814537
    [No Abstract]   [Full Text] [Related]  

  • 6. Benefits of cyclosporine absorption profiling in nephrotic syndrome: preprandial once-daily administration of cyclosporine microemulsion improves slow absorption and can standardize the absorption profile.
    Takeda A; Horike K; Onoda H; Ohtsuka Y; Yoshida A; Uchida K; Morozumi K
    Nephrology (Carlton); 2007 Apr; 12(2):197-204. PubMed ID: 17371346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of acenocoumarol on hemorheological parameters.
    Vayá A; Martínez M; Fernández A; Ripoll F; Moscardó F; Mira Y; Aznar J
    Clin Hemorheol Microcirc; 2001; 24(2):111-5. PubMed ID: 11381186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of PK-PD drug-drug interaction between acenocoumarol and amoxicillin plus clavulanic acid.
    Delavenne X; Laporte S; Demasles S; Mallouk N; Basset T; Tod M; Girard P; Mismetti P
    Fundam Clin Pharmacol; 2009 Feb; 23(1):127-35. PubMed ID: 19267776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosuvastatin-acenocoumarol interaction.
    Mondillo S; Ballo P; Galderisi M
    Clin Ther; 2005 Jun; 27(6):782-4. PubMed ID: 16117985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of nateglinide on the pharmacokinetics and pharmacodynamics of acenocoumarol.
    Sunkara G; Bigler H; Wang Y; Smith H; Prasad P; McLeod J; Ligueros-Saylan M
    Curr Med Res Opin; 2004 Jan; 20(1):41-8. PubMed ID: 14741071
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No effect of acenocoumarol therapy on levels of endothelial activation markers in sickle cell disease.
    Schnog JB; Mac Gillavry MR; Rojer RA; Meijers JC; Fijnheer R; ten Cate H; Brandjes DP; Duits AJ
    Am J Hematol; 2002 Sep; 71(1):53-5. PubMed ID: 12221677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of effect of omeprazole in oral acenocoumarol anticoagulant therapy.
    Vreeburg EM; De Vlaam-Schluter GM; Trienekens PH; Snel P; Tytgat GN
    Scand J Gastroenterol; 1997 Oct; 32(10):991-4. PubMed ID: 9361171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetic study of cyclosporine in patients with nephrotic syndrome.
    Xiaoli D; Qiang F
    J Clin Pharmacol; 2009 Jul; 49(7):782-8. PubMed ID: 19448042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time course of the drug-drug interaction of acenocoumarol-miconazole.
    Lozano R; Frutos A
    Int J Clin Pharmacol Ther; 2018 Jan; 56(1):28-30. PubMed ID: 29162215
    [No Abstract]   [Full Text] [Related]  

  • 15. Diurnal variation in the intensity of anticoagulation in atrial fibrillation.
    García A; Marín F; Sánchez B; Roldán V; Marco P
    Stroke; 2002 Jan; 33(1):322-4. PubMed ID: 11779936
    [No Abstract]   [Full Text] [Related]  

  • 16. [A patient with lessened sensitivity to acenocoumarol during a period of enteral feeding].
    van Iersel MD; Blenke AA; Kremer HP; Hekster YA
    Ned Tijdschr Geneeskd; 2004 Jun; 148(23):1155-7. PubMed ID: 15211967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythromycin-oral anticoagulants interaction.
    Grau E; Fontcuberta J; Félez J
    Arch Intern Med; 1986 Aug; 146(8):1639. PubMed ID: 3488045
    [No Abstract]   [Full Text] [Related]  

  • 18. [Absence of interaction between oral anticoagulants and influenza vaccine].
    Souto JC; Garí M; Borrell M; Fontcuberta J
    Med Clin (Barc); 1993 Nov; 101(16):637. PubMed ID: 8271869
    [No Abstract]   [Full Text] [Related]  

  • 19. Potentiation of acenocoumarol during vaginal administration of miconazole.
    Lansdorp D; Bressers HP; Dekens-Konter JA; Meyboom RH
    Br J Clin Pharmacol; 1999 Feb; 47(2):225-6. PubMed ID: 10190660
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased cyclosporine bioavailability induced by experimental nephrotic syndrome in rats.
    Medeiros M; Pérez-Urizar J; Pedraza-Chaverri J; Muñoz-Arizpe R; Castañeda-Hernández G
    Can J Physiol Pharmacol; 2007 May; 85(5):502-6. PubMed ID: 17632584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.